Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Pulmonx Corp (NQ: LUNG )

8.080 +0.180 (+2.28%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 513,735
Open 7.800
Bid (Size) 7.900 (1)
Ask (Size) 8.750 (5)
Prev. Close 7.900
Today's Range 7.700 - 8.160
52wk Range 5.670 - 14.84
Shares Outstanding 36,690,233
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Pulmonx to Report Second Quarter 2024 Financial Results on July 31, 2024
From Pulmonx Corporation
Via GlobeNewswire
5 Medical Info Systems Stocks To Buy For Stable Returns
The medical info systems industry is thriving due to the growing demand for contactless services. Amid this environment, here are some stocks in the industry that may see stable returns in 2024. 
Via Talk Markets

Performance

YTD
-36.38%
-36.38%
1 Month
+37.30%
+37.30%
3 Month
+8.89%
+8.89%
6 Month
-36.63%
-36.63%
1 Year
-39.38%
-39.38%

More News

Read More
Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Pulmonx Corporation
Via GlobeNewswire
C.H. Robinson Worldwide Posts Upbeat Results, Joins Avis Budget Group, Qualcomm, BorgWarner, Moderna And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Navigating 6 Analyst Ratings For Pulmonx
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
LUNG Stock Earnings: Pulmonx Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Pulmonx Reports First Quarter 2024 Financial Results
From Pulmonx Corporation
Via GlobeNewswire
Analyst Ratings For Pulmonx
Via Benzinga
Earnings Scheduled For February 21, 2024
Via Benzinga
Pulmonx to Report First Quarter 2024 Financial Results on May 1, 2024
From Pulmonx Corporation
Via GlobeNewswire
Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer
From Pulmonx Corporation
Via GlobeNewswire
Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Pulmonx Corporation
Via GlobeNewswire
Pulmonx Announces Treatment of the First Patient with the AeriSeal® System in CONVERT II Pivotal Trial
From Pulmonx Corporation
Via Business Wire
Why Etsy Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Pulmonx Reports Fourth Quarter and Full Year 2023 Financial Results
From Pulmonx Corporation
Via GlobeNewswire
Pulmonx Announces Retirement of CEO Glen French and Appointment of Industry Veteran Steve Williamson as President and Chief Executive Officer
From Pulmonx Corporation
Via GlobeNewswire
Pulmonx to Report Fourth Quarter and Full Year 2023 Financial Results on February 21, 2024
From Pulmonx Corporation
Via GlobeNewswire
The Honest Company Announces Appointment of Michael Barkley, Alissa Hsu Lynch, and Andrea Turner to the Board of Directors
From The Honest Company, Inc.
Via GlobeNewswire
Biotech Breakthroughs: 3 Revolutionary Stocks Redefining Healthcare
Via InvestorPlace
Pulmonx to Present at the Piper Sandler 35th Annual Healthcare Conference
From Pulmonx Corporation
Via GlobeNewswire
Pulmonx to Participate at Upcoming Investor Conferences
From Pulmonx Corporation
Via GlobeNewswire
Why JetBlue Airways Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Arista Networks, JinkoSolar, Repligen, Shutterstock And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Topics Stocks
Exposures US Equities
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.